Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-43 ...

Edwards Lifesciences Corporation (NYSE:EW) Q3 2021 Earnings Conference Call October 28, 2021 5:00 PM ET Company Participants Mike Mussallem – Chairman and Chief Executive Officer Mark Wilterding – Vice President of Investor Relations and Treasurer Scott Ullem – Chief Financial Officer Conference Call Participants Vijay Kumar – Evercore ISI Bob Hopkins – Bank of America Robert Marcus – JPMorgan Josh Jennings – Cowen Matt Miksic – Credit Suisse Danielle Antalffy – SDD Leerink Cecilia Furlong – Morgan Stanley ...

Edwards Lifesciences Corporation (NYSE:EW) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and Chief Executive Officer Scott Ullem - Chief Financial Officer Conference Call Participants Bob Hopkins - Bank of America Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Robert Marcus - JPMorgan Pito Chickering - Deutsche Bank Matt Miksic - Credit Suisse Cecilia Furlong - Morgan Stanley Travis Steed - B ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-4316614 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-431661 ...

Edwards Lifesciences Corporation (NYSE:EW) Q1 2021 Earnings Conference Call April 20, 2021 5:30 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America Robert Marcus - JPMorgan Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Joshua Jennings - Cowen and Company Cecilia Furlong - Morgan Stanley Matt Miksic - Credit Suisse Joanne Wuensch - Citigroup Danielle Antalffy - ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-4316614 (St ...

Edwards Lifesciences Corporation (NYSE:EW) Q4 2020 Earnings Conference Call January 27, 2021 5:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America David Lewis - Morgan Stanley Operator Greetings and welcome to the Edwards Lifesciences Corporation's Fourth Quarter 2020 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer s ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) (State or othe ...

Edwards Lifesciences Corporation (NYSE:EW) Q3 2020 Earnings Conference Call October 21, 2020 5:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and Chief Executive Officer Scott Ullem - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Bob Hopkins - Bank of America Joanne Wuensch - Citi Raj Denhoy - Jefferies Robbie Marcus - JPMorgan Matt Miksic - Credit Suisse Danielle Antalffy - SVB Leerink Adam Maeder - Piper Sandler M ...